Our data demonstrate that the co-expression of activated AKT and TA-combined mutations (TACO) affected postoperative prognosis in human HCC, providing strong genetic evidence that the combination of pAKT and TACO plays a pivotal role in HCC progression. This evidence concerns the gene AKT1 and hepatocellular carcinoma.